No Evidence of Association Between Undercarboxylated Osteocalcin and Incident Type 2 Diabetes. (27th February 2022)
- Record Type:
- Journal Article
- Title:
- No Evidence of Association Between Undercarboxylated Osteocalcin and Incident Type 2 Diabetes. (27th February 2022)
- Main Title:
- No Evidence of Association Between Undercarboxylated Osteocalcin and Incident Type 2 Diabetes
- Authors:
- Babey, Muriel E.
Ewing, Susan K.
Strotmeyer, Elsa S.
Napoli, Nicola
Schafer, Anne L.
Vittinghoff, Eric
Gundberg, Caren M.
Schwartz, Ann V. - Abstract:
- ABSTRACT: Mouse models suggest that undercarboxylated osteocalcin (ucOC), produced by the skeleton, protects against type 2 diabetes development, whereas human studies have been inconclusive. We aimed to determine if ucOC or total OC is associated with incident type 2 diabetes or changes in fasting glucose, insulin resistance (HOMA‐IR), or beta‐cell function (HOMA‐Beta). A subcohort ( n = 338; 50% women; 36% black) was identified from participants without diabetes at baseline in the Health, Aging, and Body Composition Study. Cases of incident type 2 diabetes ( n = 137) were defined as self‐report at an annual follow‐up visit, use of diabetes medication, or elevated fasting glucose during 8 years of follow‐up. ucOC and total OC were measured in baseline serum. Using a case‐cohort design, the association between biomarkers and incident type 2 diabetes was assessed using robust weighted Cox regression. In the subcohort, linear regression models analyzed the associations between biomarkers and changes in fasting glucose, HOMA‐IR, and HOMA‐Beta over 9 years. Higher levels of ucOC were not statistically associated with increased risk of incident type 2 diabetes (adjusted hazard ratio = 1.06 [95% confidence interval, 0.84–1.34] per 1 standard deviation [SD] increase in ucOC). Results for %ucOC and total OC were similar. Adjusted associations of ucOC, %ucOC, and total OC with changes in fasting glucose, HOMA‐IR, and HOMA‐Beta were modest and not statistically significant. We didABSTRACT: Mouse models suggest that undercarboxylated osteocalcin (ucOC), produced by the skeleton, protects against type 2 diabetes development, whereas human studies have been inconclusive. We aimed to determine if ucOC or total OC is associated with incident type 2 diabetes or changes in fasting glucose, insulin resistance (HOMA‐IR), or beta‐cell function (HOMA‐Beta). A subcohort ( n = 338; 50% women; 36% black) was identified from participants without diabetes at baseline in the Health, Aging, and Body Composition Study. Cases of incident type 2 diabetes ( n = 137) were defined as self‐report at an annual follow‐up visit, use of diabetes medication, or elevated fasting glucose during 8 years of follow‐up. ucOC and total OC were measured in baseline serum. Using a case‐cohort design, the association between biomarkers and incident type 2 diabetes was assessed using robust weighted Cox regression. In the subcohort, linear regression models analyzed the associations between biomarkers and changes in fasting glucose, HOMA‐IR, and HOMA‐Beta over 9 years. Higher levels of ucOC were not statistically associated with increased risk of incident type 2 diabetes (adjusted hazard ratio = 1.06 [95% confidence interval, 0.84–1.34] per 1 standard deviation [SD] increase in ucOC). Results for %ucOC and total OC were similar. Adjusted associations of ucOC, %ucOC, and total OC with changes in fasting glucose, HOMA‐IR, and HOMA‐Beta were modest and not statistically significant. We did not find evidence of an association of baseline undercarboxylated or total osteocalcin with risk of incident type 2 diabetes or with changes in glucose metabolism in older adults. © 2022 American Society for Bone and Mineral Research (ASBMR). … (more)
- Is Part Of:
- Journal of bone and mineral research. Volume 37:Number 5(2022)
- Journal:
- Journal of bone and mineral research
- Issue:
- Volume 37:Number 5(2022)
- Issue Display:
- Volume 37, Issue 5 (2022)
- Year:
- 2022
- Volume:
- 37
- Issue:
- 5
- Issue Sort Value:
- 2022-0037-0005-0000
- Page Start:
- 876
- Page End:
- 884
- Publication Date:
- 2022-02-27
- Subjects:
- GENERAL POPULATION STUDIES -- EPIDEMIOLOGY -- OTHER -- SYSTEMS BIOLOGY -- BONE INTERACTORS -- OTHER -- CELL/TISSUE SIGNALING -- ENDOCRINE PATHWAYS
Bones -- Metabolism -- Periodicals
Mineral metabolism -- Periodicals
612.392 - Journal URLs:
- http://onlinelibrary.wiley.com/ ↗
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1523-4681 ↗
http://www.jbmr-online.com ↗ - DOI:
- 10.1002/jbmr.4519 ↗
- Languages:
- English
- ISSNs:
- 0884-0431
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4954.255530
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21512.xml